hackettg

Class 4 Medicines Defect Information: Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension (Sandoz Limited) Drug alert number: EL (23)A/14 Date issued: 20 April 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Co-amoxiclav 125/31.25mg/5ml powder for oral suspension, PL 04416/0514 (Sandoz Limited) SNOMED [...]

The post MHRA Class 4 Medicines Defect Information: Co-amoxiclav 125/31.25mg/5ml, 250/62.5mg/5ml powder for oral suspension (Sandoz Limited) appeared first on PSNC Website.

The Drug Tariff Preface published monthly lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 April 2023. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item [...]

The post Drug Tariff Watch – April 2023 appeared first on PSNC Website.

Following representation from PSNC, the NHS Business Services Authority (NHSBSA) has added the ‘Caution – AMP level prescribing advised’ marker to oral Tacrolimus products on the Dictionary of medicines and devices (dm+d). This is in line with the MHRA guidance that oral Tacrolimus products should be prescribed and dispensed by brand name only, to minimise [...]

The post Brand name prescribing status for Tacrolimus products updated on dm+d appeared first on PSNC Website.

Drug alert number: EL(23)A/12 Date issued: 23 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited) Batch number Expiry date Pack size First distributed T16656K Mar 2024 1 19 May 2022 U11271E Jun [...]

The post MHRA Class 2 Medicines Recall: GONAPEPTYL Depot 3.75mg powder and solvent for suspension for injection (Ferring Pharmaceuticals Limited) appeared first on PSNC Website.

Drug alert number: EL (23)A/09 Date issued: 14 March 2023 The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for: Pholcodine-containing products (Various Marketing Authorisation Holders) Following the conclusion of a review of post-marketing safety data by the MHRA, all pholcodine-containing medicines are being recalled and withdrawn from the [...]

The post MHRA Class 2 Medicines Recall: Pholcodine-containing products (Various Marketing Authorisation Holders) appeared first on PSNC Website.